Interventional Neuroradiology Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$4000
Buy Report View Sample

Published: May 22, 2023 Report Code: GDME1540EPD-ST

Select Item

Interventional Neuroradiology Pipeline Market Report Overview

The key segments of interventional neuroradiology such as neurovascular embolization devices, neurovascular accessory devices, and neurovascular coiling assist devices are covered under in the report. The interventional neuroradiology pipeline market research report provides comprehensive information about the interventional neuroradiology pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Key Segments ·       Neurovascular Accessory Devices

·       Stent Retrievers

·       Flow Diversion Stents

·       Intracranial Stents

·       Embolization Coils

·       Neurovascular Embolization Devices
Key Territories ·       The US

·       Europe

·       China

·       Japan

·       Taiwan
Key Regulatory Paths ·       NMPA

·       510(k)

·       PMA

·       CE

·       TGA

·       Ninsho

·       UKCA
Leading Companies ·       Artio Medical

·       Artiria Medical SA

·       Avantec Vascular Corp

·       Balt USA LLC

·       BaseCamp Vascular

·       Beijing Honghai Minimally Invasive Technology Co Ltd

·       Bendit Technologies Ltd

·       BioCure Inc
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Interventional Neuroradiology Pipeline Market Segments

Some of the key segments in the interventional neuroradiology pipeline market are neurovascular accessory devices, stent retrievers, flow diversion stents, intracranial stents, embolization coils, and neurovascular embolization devices among others. As of May 2023, neurovascular accessory devices have the highest number of pipeline products.

Interventional Neuroradiology Pipeline Market Analysis, by Segments, 2023 (%)

Interventional Neuroradiology Pipeline Market Analysis, by Segments, 2023 (%)

For more segment insights into the interventional neuroradiology pipeline market, download a free report sample

Interventional Neuroradiology Pipeline Market Segmentation by Territories

Some of the territories in the interventional substitute pipeline market are the US, Europe, China, Japan, and Taiwan among others. As of May 2023, the US has the highest number of pipeline products.

Interventional Neuroradiology Pipeline Market Analysis, by Territories, 2023 (%)

Interventional Neuroradiology Pipeline Market Analysis, by Territories, 2023 (%)

For more territory insights into the interventional neuroradiology pipeline market, download a free report sample

Interventional Neuroradiology Pipeline Market Segmentation by Regulatory Paths

Some of the regulatory paths in the interventional substitute pipeline market are NMPA, 510(k), PMA, CE, TGA, Ninsho, and UKCA among others. As of May 2023, NMPA is the most followed pathway for pipeline products.

Interventional Neuroradiology Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

Interventional Neuroradiology Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

For more regulatory path insights into the interventional neuroradiology pipeline market, download a free report sample

Interventional Neuroradiology Pipeline Market – Competitive Landscape

Some of the key companies in the interventional substitute pipeline market are Artio Medical, Artiria Medical SA, Avantec Vascular Corp, Balt USA LLC, BaseCamp Vascular, Beijing Honghai Minimally Invasive Technology Co Ltd, Bendit Technologies Ltd, and BioCure Inc among others.

Artio Medical: Artio Medical Inc (Metactive Medical, LLC), is a medical device company that is engaged in developing innovative new medical devices to treat important unmet medical needs. The company is headquartered in the United States.

Segments Covered in the Report

Interventional Neuroradiology Pipeline Market Segments Outlook

  • Neurovascular Accessory Devices
  • Stent Retrievers
  • Flow Diversion Stents
  • Intracranial Stents
  • Embolization Coils
  • Neurovascular Embolization Devices

Interventional Neuroradiology Pipeline Market Territories Outlook

  • The US
  • Europe
  • China
  • Japan
  • Taiwan

Interventional Neuroradiology Pipeline Market Regulatory Paths Outlook

  • NMPA
  • 510(k)
  • PMA
  • CE
  • TGA
  • Ninsho
  • UKCA

Scope

  • Extensive coverage of the interventional neuroradiology under development

  • Reviews details of major pipeline products which include, product description, licensing and collaboration details, and other developmental activities

  • Reviews the major players involved in the development of interventional neuroradiology and list all their pipeline projects

  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

  • The report provides key clinical trial data of ongoing trials specific to pipeline products

  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies

  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage

  • Identify and understand important and diverse types of interventional neuroradiology under development

  • Develop market-entry and market-expansion strategies

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

AccuMedical Medical Device (Beijing) Ltd
Achieva Medical (Shanghai) Co Ltd
Acotec Scientific Holdings Ltd
Actuated Medical Inc
Alcyone Therapeutics Inc
Amnis Therapeutics Ltd
Anaconda BioMed SL
Ancure LLC
Aneuclose LLC
Aneuvas Technologies Inc
Apeliotus Technologies
Arterain Medical Inc (Inactive)
Artio Medical
Artiria Medical SA
Avantec Vascular Corp
Balt USA LLC
BaseCamp Vascular
Beijing Honghai Minimally Invasive Technology Co Ltd
Bendit Technologies Ltd
BioCure Inc
Biomedical Solutions Inc
Boston University School of Medicine
Capital Medical University
Cerenovus
Ceretrieve Ltd
Cerovations LLC
Cerus Endovascular Ltd
Codman & Shurtleff Inc
Collagen Matrix Inc
Conway Medical LLC
Corindus Vascular Robotics Inc
CranioVation
Critical Innovations LLC
CVTec Cerebrovascular Technologies GmbH
Dartmouth College
DePuy Synthes Inc
Dongguan TT Medical Inc
EchoGuide Medical, Inc. (Inactive)
Echopoint Medical Ltd
Ecole Polytechnique Federale de Lausanne
Embolx, Inc.
Endomimetics LLC
EndoShape, Inc.
EndoStream Medical Ltd
Euphrates Vascular Inc
Evasc Medical Systems Corp
Fluid Biotech Inc
Fluidx Medical Technology LLC
Gaudi Vascular, Inc.
Gentuity LLC
Guichuangtongqiao Medical Technology Co Ltd
Hangzhou Yike Medical Technology Co Ltd
Hansen Medical Inc (Inactive)
Hemo (China) Bioengineering Ltd
HeMo Bioengineering Ltd
Hibernia Medical
HoloSurgical Inc
Imperative Care Inc
Inretio Ltd
Insera Therapeutics LLC
InspireMD Inc
Integra LifeSciences Holdings Corp
Irras AB
iVascular SLU
Jiangsu Nuanyang Medical Instrument Co Ltd
Juhui Medical Technology (Shenzhen) Co Ltd
Liaoning Yinyi Biotechnology Co Ltd
LuSeed Vascular
Mayo Clinic
Medikit Co Ltd
Medtronic Plc
Merlin MD Pte. Ltd.
MicroPort NeuroTech Ltd
MicroPort Scientific Corp
MicroVention Inc
Minor MicroPort
MiVi Neuroscience LLC
Monarch Biosciences Inc
Nanjing Kanite Medical Technology Co Ltd
Nanjing SealMed Medical Technology Corp Ltd
Navisonics Inc
NEOS Surgery SL
Neurogami Medical Inc
NeuroInterventional Therapeutics, Inc.
Neurosigma Inc
Neurosyntec LLC. (Inactive)
NeuroVasc Technologies Inc
NexGen Medical Systems Inc
North Carolina State University
Novasentis Inc
Occam Design LLC
OccluTex Medical BV
OrbusNeich
Oxford Endovascular Ltd
Palmaz Scientific Inc (Inactive)
Peijia Medical Ltd
Pennsylvania State University
Perflow Medical, Ltd.
Perfuze Ltd
PhotoThera Inc (Inactive)
Purdue University
Q'Apel Medical LLC
Qvanteq AG
RAM Medical Innovations Inc
Rapid Medical
RapidPulse Inc
Rontis AG
Route 92 Medical Inc
Rutgers The State University of New Jersey
Sensome SAS
Sequent Medical, Inc.
Shanghai Healing Medical Instruments Co Ltd
Shanghai HeartCare Medical Technology Co Ltd
Shanghai MicroPort Medical Group Co Ltd
Shanghai Pulse Medical Technology Inc
Shanghai Weimi Medical Technology Co Ltd
Shape Memory Therapeutics, Inc.
Shenzhen Century MicroPort Medical Technology Co Ltd
Silk Road Medical Inc
Sinomed Neurovita Technology Inc
SinoMedCare Biotech Co Ltd
Skynor Medical (Shanghai) Co Ltd
Sree Chitra Tirunal Institute for Medical Sciences & Technology
Stryker Corp
Stryker Neurovascular
Suzhou Yinluo Medical Devices Co Ltd
Suzhou Zenith Vascular Scitech Co Ltd
Suzhou Zhongtian Medical Device Technology Co Ltd
Terumo Corp
Transverse Medical Inc
Triticum Medical Ltd.
Twin Star Medical Inc
UNandUP LLC
University of California Los Angeles
University of California San Diego
University of California San Francisco
University of Minnesota
University of Pennsylvania
University of Pittsburgh
University of South Florida
University of Toledo
University of Wisconsin Madison
Vena Medical
Vesalio LLC
Viket Medical Corporation
Wallaby Medical Inc
Weill Cornell Medical College
Xtract Medical Inc
Zhejiang Kindly Medical Devices Co Ltd
Zhuhai Tonbridge Medical Tech Co Ltd
Zylox-Tonbridge Medical Technology Co Ltd

Table of Contents

1 Table of Contents 3

1.1 List of Tables 11

1.2 List of Figures 28

2 Introduction 29

2.1 Interventional Neuroradiology Overview 29

3 Products under Development 31

3.1 Interventional Neuroradiology – Pipeline Products by Stage of Development 31

3.2 Interventional Neuroradiology – Pipeline Products by Segment 32

3.3 Interventional Neuroradiology – Pipeline Products by Territory 33

3.4 Interventional Neuroradiology – Pipeline Products by Regulatory Path 35

3.5 Interventional Neuroradiology – Pipeline Products by Estimated Approval Date 36

3.6 Interventional Neuroradiology – Ongoing Clinical Trials 37

4 Interventional Neuroradiology – Pipeline Products under Development by Companies 38

4.1 Interventional Neuroradiology Companies – Pipeline Products by Stage of Development 38

4.2 Interventional Neuroradiology – Pipeline Products by Stage of Development 44

5 Interventional Neuroradiology Companies and Product Overview 52

5.1 AccuMedical Medical Device (Beijing) Ltd Company Overview 52

5.1.1 AccuMedical Medical Device (Beijing) Ltd Pipeline Products & Ongoing Clinical Trials Overview 52

5.2 Achieva Medical (Shanghai) Co Ltd Company Overview 54

5.2.1 Achieva Medical (Shanghai) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 54

5.3 Acotec Scientific Holdings Ltd Company Overview 60

5.3.1 Acotec Scientific Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview 60

5.4 Actuated Medical Inc Company Overview 64

5.4.1 Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 64

5.5 Alcyone Therapeutics Inc Company Overview 65

5.5.1 Alcyone Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 65

5.6 Amnis Therapeutics Ltd Company Overview 66

5.6.1 Amnis Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview 66

5.7 Anaconda BioMed SL Company Overview 67

5.7.1 Anaconda BioMed SL Pipeline Products & Ongoing Clinical Trials Overview 67

5.8 Ancure LLC Company Overview 71

5.8.1 Ancure LLC Pipeline Products & Ongoing Clinical Trials Overview 71

5.9 Aneuclose LLC Company Overview 72

5.9.1 Aneuclose LLC Pipeline Products & Ongoing Clinical Trials Overview 72

5.10 Aneuvas Technologies Inc Company Overview 74

5.10.1 Aneuvas Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 74

5.11 Apeliotus Technologies Company Overview 75

5.11.1 Apeliotus Technologies Pipeline Products & Ongoing Clinical Trials Overview 75

5.12 Arterain Medical Inc (Inactive) Company Overview 76

5.12.1 Arterain Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 76

5.13 Artio Medical Company Overview 77

5.13.1 Artio Medical Pipeline Products & Ongoing Clinical Trials Overview 77

5.14 Artiria Medical SA Company Overview 80

5.14.1 Artiria Medical SA Pipeline Products & Ongoing Clinical Trials Overview 80

5.15 Avantec Vascular Corp Company Overview 84

5.15.1 Avantec Vascular Corp Pipeline Products & Ongoing Clinical Trials Overview 84

5.16 Balt USA LLC Company Overview 86

5.16.1 Balt USA LLC Pipeline Products & Ongoing Clinical Trials Overview 86

5.17 BaseCamp Vascular Company Overview 89

5.17.1 BaseCamp Vascular Pipeline Products & Ongoing Clinical Trials Overview 89

5.18 Beijing Honghai Minimally Invasive Technology Co Ltd Company Overview 91

5.18.1 Beijing Honghai Minimally Invasive Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 91

5.19 Bendit Technologies Ltd Company Overview 93

5.19.1 Bendit Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 93

5.20 BioCure Inc Company Overview 95

5.20.1 BioCure Inc Pipeline Products & Ongoing Clinical Trials Overview 95

5.21 Biomedical Solutions Inc Company Overview 97

5.21.1 Biomedical Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 97

5.22 Boston University School of Medicine Company Overview 98

5.22.1 Boston University School of Medicine Pipeline Products & Ongoing Clinical Trials Overview 98

5.23 Capital Medical University Company Overview 99

5.23.1 Capital Medical University Pipeline Products & Ongoing Clinical Trials Overview 99

5.24 Cerenovus Company Overview 100

5.24.1 Cerenovus Pipeline Products & Ongoing Clinical Trials Overview 100

5.25 Ceretrieve Ltd Company Overview 103

5.25.1 Ceretrieve Ltd Pipeline Products & Ongoing Clinical Trials Overview 103

5.26 Cerovations LLC Company Overview 104

5.26.1 Cerovations LLC Pipeline Products & Ongoing Clinical Trials Overview 104

5.27 Cerus Endovascular Ltd Company Overview 105

5.27.1 Cerus Endovascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 105

5.28 Codman & Shurtleff Inc Company Overview 110

5.28.1 Codman & Shurtleff Inc Pipeline Products & Ongoing Clinical Trials Overview 110

5.29 Collagen Matrix Inc Company Overview 114

5.29.1 Collagen Matrix Inc Pipeline Products & Ongoing Clinical Trials Overview 114

5.30 Conway Medical LLC Company Overview 115

5.30.1 Conway Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 115

5.31 Corindus Vascular Robotics Inc Company Overview 116

5.31.1 Corindus Vascular Robotics Inc Pipeline Products & Ongoing Clinical Trials Overview 116

5.32 CranioVation Company Overview 117

5.32.1 CranioVation Pipeline Products & Ongoing Clinical Trials Overview 117

5.33 Critical Innovations LLC Company Overview 118

5.33.1 Critical Innovations LLC Pipeline Products & Ongoing Clinical Trials Overview 118

5.34 CVTec Cerebrovascular Technologies GmbH Company Overview 119

5.34.1 CVTec Cerebrovascular Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 119

5.35 Dartmouth College Company Overview 120

5.35.1 Dartmouth College Pipeline Products & Ongoing Clinical Trials Overview 120

5.36 DePuy Synthes Inc Company Overview 122

5.36.1 DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 122

5.37 Dongguan TT Medical Inc Company Overview 125

5.37.1 Dongguan TT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 125

5.38 EchoGuide Medical, Inc. (Inactive) Company Overview 128

5.38.1 EchoGuide Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 128

5.39 Echopoint Medical Ltd Company Overview 129

5.39.1 Echopoint Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 129

5.40 Ecole Polytechnique Federale de Lausanne Company Overview 130

5.40.1 Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview 130

5.41 Embolx, Inc. Company Overview 131

5.41.1 Embolx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 131

5.42 Endomimetics LLC Company Overview 132

5.42.1 Endomimetics LLC Pipeline Products & Ongoing Clinical Trials Overview 132

5.43 EndoShape, Inc. Company Overview 134

5.43.1 EndoShape, Inc. Pipeline Products & Ongoing Clinical Trials Overview 134

5.44 EndoStream Medical Ltd Company Overview 135

5.44.1 EndoStream Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 135

5.45 Euphrates Vascular Inc Company Overview 138

5.45.1 Euphrates Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 138

5.46 Evasc Medical Systems Corp Company Overview 139

5.46.1 Evasc Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview 139

5.47 Fluid Biotech Inc Company Overview 143

5.47.1 Fluid Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 143

5.48 Fluidx Medical Technology LLC Company Overview 144

5.48.1 Fluidx Medical Technology LLC Pipeline Products & Ongoing Clinical Trials Overview 144

5.49 Gaudi Vascular, Inc. Company Overview 145

5.49.1 Gaudi Vascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 145

5.50 Gentuity LLC Company Overview 146

5.50.1 Gentuity LLC Pipeline Products & Ongoing Clinical Trials Overview 146

5.51 Guichuangtongqiao Medical Technology Co Ltd Company Overview 147

5.51.1 Guichuangtongqiao Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 147

5.52 Hangzhou Yike Medical Technology Co Ltd Company Overview 149

5.52.1 Hangzhou Yike Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 149

5.53 Hansen Medical Inc (Inactive) Company Overview 152

5.53.1 Hansen Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 152

5.54 Hemo (China) Bioengineering Ltd Company Overview 153

5.54.1 Hemo (China) Bioengineering Ltd Pipeline Products & Ongoing Clinical Trials Overview 153

5.55 HeMo Bioengineering Ltd Company Overview 156

5.55.1 HeMo Bioengineering Ltd Pipeline Products & Ongoing Clinical Trials Overview 156

5.56 Hibernia Medical Company Overview 169

5.56.1 Hibernia Medical Pipeline Products & Ongoing Clinical Trials Overview 169

5.57 HoloSurgical Inc Company Overview 170

5.57.1 HoloSurgical Inc Pipeline Products & Ongoing Clinical Trials Overview 170

5.58 Imperative Care Inc Company Overview 171

5.58.1 Imperative Care Inc Pipeline Products & Ongoing Clinical Trials Overview 171

5.59 Inretio Ltd Company Overview 174

5.59.1 Inretio Ltd Pipeline Products & Ongoing Clinical Trials Overview 174

5.60 Insera Therapeutics LLC Company Overview 175

5.60.1 Insera Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview 175

5.61 InspireMD Inc Company Overview 177

5.61.1 InspireMD Inc Pipeline Products & Ongoing Clinical Trials Overview 177

5.62 Integra LifeSciences Holdings Corp Company Overview 178

5.62.1 Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview 178

5.63 Irras AB Company Overview 180

5.63.1 Irras AB Pipeline Products & Ongoing Clinical Trials Overview 180

5.64 iVascular SLU Company Overview 181

5.64.1 iVascular SLU Pipeline Products & Ongoing Clinical Trials Overview 181

5.65 Jiangsu Nuanyang Medical Instrument Co Ltd Company Overview 182

5.65.1 Jiangsu Nuanyang Medical Instrument Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 182

5.66 Juhui Medical Technology (Shenzhen) Co Ltd Company Overview 185

5.66.1 Juhui Medical Technology (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 185

5.67 Liaoning Yinyi Biotechnology Co Ltd Company Overview 188

5.67.1 Liaoning Yinyi Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 188

5.68 LuSeed Vascular Company Overview 191

5.68.1 LuSeed Vascular Pipeline Products & Ongoing Clinical Trials Overview 191

5.69 Mayo Clinic Company Overview 192

5.69.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 192

5.70 Medikit Co Ltd Company Overview 193

5.70.1 Medikit Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 193

5.71 Medtronic Plc Company Overview 197

5.71.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 197

5.72 Merlin MD Pte. Ltd. Company Overview 204

5.72.1 Merlin MD Pte. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 204

5.73 MicroPort NeuroTech Ltd Company Overview 205

5.73.1 MicroPort NeuroTech Ltd Pipeline Products & Ongoing Clinical Trials Overview 205

5.74 MicroPort Scientific Corp Company Overview 211

5.74.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 211

5.75 MicroVention Inc Company Overview 216

5.75.1 MicroVention Inc Pipeline Products & Ongoing Clinical Trials Overview 216

5.76 Minor MicroPort Company Overview 218

5.76.1 Minor MicroPort Pipeline Products & Ongoing Clinical Trials Overview 218

5.77 MiVi Neuroscience LLC Company Overview 222

5.77.1 MiVi Neuroscience LLC Pipeline Products & Ongoing Clinical Trials Overview 222

5.78 Monarch Biosciences Inc Company Overview 227

5.78.1 Monarch Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 227

5.79 Nanjing Kanite Medical Technology Co Ltd Company Overview 228

5.79.1 Nanjing Kanite Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 228

5.80 Nanjing SealMed Medical Technology Corp Ltd Company Overview 229

5.80.1 Nanjing SealMed Medical Technology Corp Ltd Pipeline Products & Ongoing Clinical Trials Overview 229

5.81 Navisonics Inc Company Overview 230

5.81.1 Navisonics Inc Pipeline Products & Ongoing Clinical Trials Overview 230

5.82 NEOS Surgery SL Company Overview 231

5.82.1 NEOS Surgery SL Pipeline Products & Ongoing Clinical Trials Overview 231

5.83 Neurogami Medical Inc Company Overview 233

5.83.1 Neurogami Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 233

5.84 NeuroInterventional Therapeutics, Inc. Company Overview 235

5.84.1 NeuroInterventional Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 235

5.85 Neurosigma Inc Company Overview 237

5.85.1 Neurosigma Inc Pipeline Products & Ongoing Clinical Trials Overview 237

5.86 Neurosyntec LLC. (Inactive) Company Overview 239

5.86.1 Neurosyntec LLC. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 239

5.87 NeuroVasc Technologies Inc Company Overview 240

5.87.1 NeuroVasc Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 240

5.88 NexGen Medical Systems Inc Company Overview 247

5.88.1 NexGen Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 247

5.89 North Carolina State University Company Overview 248

5.89.1 North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview 248

5.90 Novasentis Inc Company Overview 249

5.90.1 Novasentis Inc Pipeline Products & Ongoing Clinical Trials Overview 249

5.91 Occam Design LLC Company Overview 250

5.91.1 Occam Design LLC Pipeline Products & Ongoing Clinical Trials Overview 250

5.92 OccluTex Medical BV Company Overview 251

5.92.1 OccluTex Medical BV Pipeline Products & Ongoing Clinical Trials Overview 251

5.93 OrbusNeich Company Overview 252

5.93.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview 252

5.94 Oxford Endovascular Ltd Company Overview 258

5.94.1 Oxford Endovascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 258

5.95 Palmaz Scientific Inc (Inactive) Company Overview 259

5.95.1 Palmaz Scientific Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 259

5.96 Peijia Medical Ltd Company Overview 260

5.96.1 Peijia Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 260

5.97 Pennsylvania State University Company Overview 263

5.97.1 Pennsylvania State University Pipeline Products & Ongoing Clinical Trials Overview 263

5.98 Perflow Medical, Ltd. Company Overview 264

5.98.1 Perflow Medical, Ltd. Pipeline Products & Ongoing Clinical Trials Overview 264

5.99 Perfuze Ltd Company Overview 266

5.99.1 Perfuze Ltd Pipeline Products & Ongoing Clinical Trials Overview 266

5.100 PhotoThera Inc (Inactive) Company Overview 269

5.100.1 PhotoThera Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 269

5.101 Purdue University Company Overview 274

5.101.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview 274

5.102 Q’Apel Medical LLC Company Overview 275

5.102.1 Q’Apel Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 275

5.103 Qvanteq AG Company Overview 276

5.103.1 Qvanteq AG Pipeline Products & Ongoing Clinical Trials Overview 276

5.104 RAM Medical Innovations Inc Company Overview 277

5.104.1 RAM Medical Innovations Inc Pipeline Products & Ongoing Clinical Trials Overview 277

5.105 Rapid Medical Company Overview 278

5.105.1 Rapid Medical Pipeline Products & Ongoing Clinical Trials Overview 278

5.106 RapidPulse Inc Company Overview 283

5.106.1 RapidPulse Inc Pipeline Products & Ongoing Clinical Trials Overview 283

5.107 Rontis AG Company Overview 288

5.107.1 Rontis AG Pipeline Products & Ongoing Clinical Trials Overview 288

5.108 Route 92 Medical Inc Company Overview 289

5.108.1 Route 92 Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 289

5.109 Rutgers The State University of New Jersey Company Overview 293

5.109.1 Rutgers The State University of New Jersey Pipeline Products & Ongoing Clinical Trials Overview 293

5.110 Sensome SAS Company Overview 294

5.110.1 Sensome SAS Pipeline Products & Ongoing Clinical Trials Overview 294

5.111 Sequent Medical, Inc. Company Overview 297

5.111.1 Sequent Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 297

5.112 Shanghai Healing Medical Instruments Co Ltd Company Overview 298

5.112.1 Shanghai Healing Medical Instruments Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 298

5.113 Shanghai HeartCare Medical Technology Co Ltd Company Overview 299

5.113.1 Shanghai HeartCare Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 299

5.114 Shanghai MicroPort Medical Group Co Ltd Company Overview 312

5.114.1 Shanghai MicroPort Medical Group Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 312

5.115 Shanghai Pulse Medical Technology Inc Company Overview 313

5.115.1 Shanghai Pulse Medical Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 313

5.116 Shanghai Weimi Medical Technology Co Ltd Company Overview 314

5.116.1 Shanghai Weimi Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 314

5.117 Shape Memory Therapeutics, Inc. Company Overview 317

5.117.1 Shape Memory Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 317

5.118 Shenzhen Century MicroPort Medical Technology Co Ltd Company Overview 321

5.118.1 Shenzhen Century MicroPort Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 321

5.119 Silk Road Medical Inc Company Overview 324

5.119.1 Silk Road Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 324

5.120 Sinomed Neurovita Technology Inc Company Overview 327

5.120.1 Sinomed Neurovita Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 327

5.121 SinoMedCare Biotech Co Ltd Company Overview 330

5.121.1 SinoMedCare Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 330

5.122 Skynor Medical (Shanghai) Co Ltd Company Overview 331

5.122.1 Skynor Medical (Shanghai) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 331

5.123 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 334

5.123.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 334

5.124 Stryker Corp Company Overview 337

5.124.1 Stryker Corp Pipeline Products & Ongoing Clinical Trials Overview 337

5.125 Stryker Neurovascular Company Overview 338

5.125.1 Stryker Neurovascular Pipeline Products & Ongoing Clinical Trials Overview 338

5.126 Suzhou Yinluo Medical Devices Co Ltd Company Overview 341

5.126.1 Suzhou Yinluo Medical Devices Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 341

5.127 Suzhou Zenith Vascular Scitech Co Ltd Company Overview 342

5.127.1 Suzhou Zenith Vascular Scitech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 342

5.128 Suzhou Zhongtian Medical Device Technology Co Ltd Company Overview 345

5.128.1 Suzhou Zhongtian Medical Device Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 345

5.129 Terumo Corp Company Overview 347

5.129.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 347

5.130 Transverse Medical Inc Company Overview 350

5.130.1 Transverse Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 350

5.131 Triticum Medical Ltd. Company Overview 351

5.131.1 Triticum Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 351

5.132 Twin Star Medical Inc Company Overview 352

5.132.1 Twin Star Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 352

5.133 UNandUP LLC Company Overview 353

5.133.1 UNandUP LLC Pipeline Products & Ongoing Clinical Trials Overview 353

5.134 University of California Los Angeles Company Overview 354

5.134.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 354

5.135 University of California San Diego Company Overview 358

5.135.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 358

5.136 University of California San Francisco Company Overview 359

5.136.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 359

5.137 University of Minnesota Company Overview 361

5.137.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 361

5.138 University of Pennsylvania Company Overview 362

5.138.1 University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview 362

5.139 University of Pittsburgh Company Overview 364

5.139.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 364

5.140 University of South Florida Company Overview 365

5.140.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 365

5.141 University of Toledo Company Overview 366

5.141.1 University of Toledo Pipeline Products & Ongoing Clinical Trials Overview 366

5.142 University of Wisconsin Madison Company Overview 367

5.142.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 367

5.143 Vena Medical Company Overview 370

5.143.1 Vena Medical Pipeline Products & Ongoing Clinical Trials Overview 370

5.144 Vesalio LLC Company Overview 373

5.144.1 Vesalio LLC Pipeline Products & Ongoing Clinical Trials Overview 373

5.145 Viket Medical Corporation Company Overview 382

5.145.1 Viket Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 382

5.146 Wallaby Medical Inc Company Overview 383

5.146.1 Wallaby Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 383

5.147 Weill Cornell Medical College Company Overview 385

5.147.1 Weill Cornell Medical College Pipeline Products & Ongoing Clinical Trials Overview 385

5.148 Xtract Medical Inc Company Overview 386

5.148.1 Xtract Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 386

5.149 Zhejiang Kindly Medical Devices Co Ltd Company Overview 387

5.149.1 Zhejiang Kindly Medical Devices Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 387

5.150 Zhuhai Tonbridge Medical Tech Co Ltd Company Overview 388

5.150.1 Zhuhai Tonbridge Medical Tech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 388

5.151 Zylox-Tonbridge Medical Technology Co Ltd Company Overview 392

5.151.1 Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 392

6 Interventional Neuroradiology- Recent Developments 406

6.1 May 15, 2023: Asahi Intecc Co. announces consolidated financial results for the nine months ended March 31, 2023 406

6.2 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023 406

6.3 Apr 26, 2023: Merit Medical reports results for first quarter March 31, 2023 406

6.4 Apr 26, 2023: MicroPort announces annual results for 2022 407

6.5 Apr 20, 2023: Anaconda Biomed names new chairperson, appoints chief medical officer 407

6.6 Apr 18, 2023: Johnson & Johnson Reports Q1 2023 Results 408

6.7 Apr 12, 2023: Medtronic has a layoff in California 410

6.8 Apr 11, 2023: J&J talc unit 2nd bankruptcy must be dismissed 410

6.9 Apr 06, 2023: Merit Medical Systems to Announce First Quarter 2023 Results on April 26, 2023 411

6.10 Mar 31, 2023: Nexstim Resolutions of the Annual General Meeting of Shareholders 411

6.11 Mar 30, 2023: Zylox-Tonbridge Announces Financial Results for 2022: Revenue Increases by

87.8% YOY to RMB 334 million and Gross Profit Reaches RMB 253 million 415

6.12 Mar 28, 2023: Stryker announces Annual Meeting of Shareholders 416

6.13 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company 416

6.14 Mar 10, 2023: Nexstim Invitation to the Annual General Meeting 416

6.15 Mar 08, 2023: UCSF Health Appoints Two Prominent Healthcare Executives to Senior Leadership Positions 417

6.16 Mar 06, 2023: Axogen Appoints Marc Began as Executive Vice President and General Counsel 418

6.17 Feb 27, 2023: Nexstim Announces Financial Results January–December 2022 418

6.18 Feb 14, 2023: Asahi Intecc Announces Consolidated Financial Results for the Six Months Ended December 31, 2022 422

6.19 Feb 13, 2023: Axogen Appoints Jens Schroeder Kemp as Chief Marketing Officer 424

6.20 Feb 09, 2023: Terumo Notice Concerning Revision of the Full-Year Financial Guidance for Fiscal Year Ending March 31, 2023 424

6.21 Feb 09, 2023: Terumo Corp Announces Consolidated Financial Results for the Third Quarter Ended December 31, 2022 424

6.22 Feb 07, 2023: Silk Road Medical to Report Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023 425

6.23 Feb 03, 2023: Merit Medical Systems to Announce Fourth Quarter and Year End 2022 Results and Issue Fiscal Year 2023 Guidance on February 22, 2023 426

6.24 Jan 17, 2023: Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2022 Financial Results 426

6.25 Dec 17, 2022: Nexstim announces Changes in the management team 426

6.26 Dec 13, 2022: Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results 427

6.27 Dec 07, 2022: Cook Medical welcomes Dr. John A. Kaufman as Chief Medical Officer 427

6.28 Dec 07, 2022: Johnson & Johnson to Participate in the 41st Annual J.P. Morgan Healthcare Conference 428

6.29 Nov 23, 2022: Medtronic Reports Quarterly Earnings 428

6.30 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results 428

6.31 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday 434

6.32 Nov 11, 2022: Asahi Intecc Consolidated Financial Results for the Three Months Ended September 30, 2022 434

6.33 Nov 10, 2022: Terumo Corp Announces Consolidated Financial Results for the Second Quarter Ended September 30, 2022 435

6.34 Nov 01, 2022: Voyager Therapeutics Announces Third Quarter 2022 Conference Call and Webcast 435

6.35 Oct 31, 2022: Axogen announces the appointment of Adrian Tyndall, M.D. MPH, FACEP to its Board of Directors and the retirement of founding Director Mark Gold, M.D. 435

6.36 Oct 18, 2022: Johnson & Johnson Reports Q3 2022 Results 436

6.37 Oct 13, 2022: Merit Medical Systems to Announce Third Quarter Results on October 26, 2022 438

6.38 Sep 29, 2022: Neurocrine Biosciences Appoints Dr. Ingrid Delaet as Chief Regulatory Officer 439

6.39 Sep 22, 2022: Axogen to Participate in the 77th Annual Meeting of the American Society for Surgery of the Hand 439

6.40 Sep 15, 2022: Zylox-Tonbridge Medical Technology Co Ltd announced interim report for 2022 440

6.41 Sep 13, 2022: Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results 440

6.42 Sep 07, 2022: Voyager Therapeutics Appoints Peter Pfreundschuh as CFO; Todd Carter, Ph.D., as Chief Scientific Officer; and Trista Morrison as SVP Corporate Affairs 440

6.43 Sep 07, 2022: Medtronic to appear at September investor conferences 441

6.44 Aug 24, 2022: Johnson & Johnson Appoints Larry Merlo as Non-Executive Chair Designate of Planned New Consumer Health Company 441

6.45 Aug 24, 2022: JNJ Appoints Merlo as Non-Executive Chair Designate 442

6.46 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results 442

6.47 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results 445

6.48 Aug 16, 2022: Boston Scientific Announces Upcoming Conference Schedule 447

6.49 Aug 12, 2022: Nexstim Announces Half-year Report January 1 – June 30, 2022 (Unaudited) 448

6.50 Aug 09, 2022: Johnson & Johnson to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference 451

6.51 Aug 08, 2022: ClearPoint Neuro Announces Appointment of Mary McNamara-Cullinane as Vice President of Regulatory Affairs 451

6.52 Aug 04, 2022: Voyager Therapeutics Prioritizes Pipeline and Reports Second Quarter 2022 Financial and Operating Results 452

6.53 Aug 03, 2022: Axogen Reports 2022 Second Quarter Financial Results 455

6.54 Aug 02, 2022: Johnson & Johnson to Participate in the 2022 Wells Fargo Securities Healthcare Conference 456

6.55 Aug 02, 2022: Voyager Therapeutics to Present Second Quarter 2022 Results and Corporate Update 457

6.56 Jul 29, 2022: Axogen to present at Canaccord Genuity’s 42nd Annual Growth Conference 457

6.57 Jul 28, 2022: Voyager Therapeutics Appoints Catherine J. Mackey, Ph.D. to its Board of Directors 457

6.58 Jul 27, 2022: Merit Medical Reports Results for Quarter Ended June 30, 2022 458

6.59 Jul 24, 2022: Annapolis Financial Services Has $359,000 Stake in Johnson & Johnson 459

6.60 Jul 20, 2022: Johnson & Johnson cuts sales forecasts 459

6.61 Jul 18, 2022: Johnson & Johnson’s Executive Vice President, General Counsel Michael Ullmann to Retire; Elizabeth Forminard Named General Counsel, Effective October 17, 2022 459

6.62 Jul 14, 2022: Merit Medical Systems to Announce Second Quarter Results on July 27, 2022 460

6.63 Jul 12, 2022: Aspire & USF Pass $10M in ticket & donation revenue 460

6.64 Jul 11, 2022: Axogen Appoints William Burke to Board of Directors 461

6.65 Jul 08, 2022: Cordis Names Bryan Loo President of Asia-pacific Region 461

6.66 Jun 27, 2022: Medtronic Board appoints Lidia Fonseca as a new director 462

6.67 May 31, 2022: Silk Road Medical Extends Cash Runway by Securing up to $250 Million in Debt Financing 463

6.68 May 30, 2022: Nexstim to Present at Redeye Growth Day 2022 463

6.69 May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results 463

6.70 May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase 463

7 Appendix 464

7.1 Methodology 464

7.2 About GlobalData 467

7.3 Contact Us 467

7.4 Disclaimer 467

Frequently asked questions

Interventional Neuroradiology Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies thematic reports
Currency USD
$4,000

Can be used by individual purchaser only

Most Popular
$8,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Interventional Neuroradiology Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Interventional Neuroradiology reports
Medical Devices
New
Clinical Chemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | November 2023
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | November 2023
Medical Devices
United States Surgical Energy Instruments Market Size (Value, Volume, ASP)…
$500 | December 2019
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Interventional Neuroradiology Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Interventional Neuroradiology Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more